At a glance
ClinicalIndex Comparison RecordN/ACompleted· 120 enrolled
Drug / intervention
Fortiva™ Porcine Dermis +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Prospective Study Comparing Fortiva™ Porcine Dermis vs. Strattice™ Reconstructive Tissue Matrix in Patients Undergoing Complex Open Primary Ventral Hernia Repair
In Brief
A clinical study evaluating Fortiva™ Porcine Dermis and Strattice™ Reconstructive Tissue Matrix for Ventral Hernia. Completed, enrolled 120 participants across 1 site.
Detailed Summary
The objective of this study is to compare the effectiveness of Fortiva Porcine Dermis versus Strattice Reconstructive Tissue Matrix for the underlay reinforcement of complex ventral hernia repair and assess post-operative complication rates, long term hernia recurrence rates.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsVentral Hernia
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedOct 2015
Enrollment StartDec 2015
Primary CompletionSep 2023
TodayJul 2026
First PostedOct 27, 2015
Enrollment StartDec 2, 2015
Primary CompletionSep 19, 2023
TodayJul 2, 2026
Enrollment to primary: 7.8 yearsPosted 10.7 years ago
Interventions
Fortiva™ Porcine Dermisdevice
Fortiva Porcine Dermis implantation during repair of complex ventral hernia
Strattice™ Reconstructive Tissue Matrixdevice
Strattice tissue matrix implanted during repair of complex ventral hernia